Institutional investors hold a majority ownership of MRK through the 77.22% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2019, these large investors purchased a net $22.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VANGUARD GLOBAL ADVISERS LLC Bought 7.7 Million shares of Merck & Co Inc
MASSACHUSETTS FINANCIAL SERVICES... Bought 6.7 Million shares of Merck & Co Inc
FRANKLIN MUTUAL ADVISERS LLC Bought 4.4 Million shares of Merck & Co Inc